Hepatitis C – Medxy AI

Hepatitis C Screening Among Persons Experiencing Homelessness in Emergency Departments: Insights from the DETECT Hep C Screening Trial and Related Evidence

By MedXY 07/17/2026

Emergency departments serve as vital venues for hepatitis C virus screening, particularly for persons experiencing homelessness who exhibit higher HCV prevalence and face healthcare access barriers. Evidence supports nontargeted screening in EDs to improve detection and engagement in this vulnerable population.

Hematology-Oncology Infectious Diseases news

Hepatitis C Eradication with Direct-Acting Antivirals: A Paradigm Shift in the Treatment of Indolent B-Cell Lymphomas

By MedXY 12/31/2025

Long-term data from the BArT study and prospective observational trials demonstrate that direct-acting antivirals (DAAs) can achieve 100% viral clearance and durable hematologic responses in HCV-associated indolent lymphomas, potentially replacing chemotherapy as a first-line intervention.

Emergency Medicine Infectious Diseases Public Health Specialties

Optimizing Hepatitis C Screening in Emergency Departments: Insights from the DETECT Hep C Randomized Clinical Trial

By MedXY 09/11/2025

The DETECT Hep C trial demonstrates nontargeted HCV screening in emergency departments identifies more new infections than risk-based approaches, though linkage to care remains suboptimal, underscoring the need for innovative treatment models.

Infectious Diseases news Specialties

Low Hepatitis C Treatment Rates in Children: Understanding the Barriers and Opportunities

By MedXY 07/29/2025

A study published in Pediatrics reveals low rates of hepatitis C treatment among children, highlighting significant racial disparities and access challenges.